Lam Research Corporation (LRCX) — closed signal from January 17, 2026
Target reached Published before the outcome was known, scored automatically when the window closed on April 17, 2026.
Predicted vs. what happened
What happened
Reached its target in 83 days.
The thesis — published January 17, 2026
Lam Research makes machines that chip factories need. News about large Taiwan-U.S. chip investments and steady equipment innovation keeps demand prospects positive. The stock moves quickly, so for a 0-3 month trade it is safer to buy on pullbacks when buying interest steadies, rather than chasing recent highs.
Primary drivers
- Spending on AI chips boosts demand for Lam's etch and deposition tools
- News of Taiwan-U.S. chip investment improves industry spending outlook
- Ongoing equipment innovation keeps Lam positioned as a leader
- Buying on pullbacks can limit losses if the stock swings sharply
How it played out
LRCX: target reached in 83 days
Lyra published LRCX at 222.96 on January 17, 2026, with 20% expected growth and a 267.55 target. The thesis pointed to demand for Lam's etch and deposition tools from artificial intelligence chip spending, Taiwan-U.S. chip investment news, ongoing equipment innovation, and a preference for buying pullbacks because the stock moved quickly.
Inside the window, LRCX reached a 273.43 peak on April 14, 2026. The peak gain was 22.6%, and the target was reached in 83 days. The stock ended the window at 267.60 on April 17, 2026. The published thesis played out.
What happened during the window
On January 28, 2026, Lam Research reported fiscal second-quarter adjusted earnings of 1.27 per share on sales of 5.34 billion. On March 11, 2026, IBM and Lam Research announced a five-year collaboration on High NA EUV dry resist technology.
Prices are shown split- and dividend-adjusted, matching what public charts show today.
Read the next call before it closes.
This is one signal, scored after the fact. Today’s picks come with the same plain-language thesis — published before anyone knows the outcome.